Psilocybin (Usona Institute)
Psilocybin (Usona Institute) is a pharmaceutical drug with 8 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
4
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of Psilocybin Under Anesthesia Controlled by EEG
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
Psilocybin to Treat Depression in Spinal Cord Injury
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Clinical Trials (8)
Study of Psilocybin Under Anesthesia Controlled by EEG
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
Psilocybin to Treat Depression in Spinal Cord Injury
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Psilocybin After Trauma Surgery for Pain
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Frontline Clinician Psilocybin Study
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8